Antimalarial agents: Closing the gate on toll‐like receptors?
Open Access
- 28 September 2006
- journal article
- editorial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (10) , 3068-3070
- https://doi.org/10.1002/art.22157
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8The Journal of Experimental Medicine, 2005
- Regulation of lung injury and repair by Toll-like receptors and hyaluronanNature Medicine, 2005
- Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosusThe Journal of Experimental Medicine, 2005
- Toll‐like receptors, endogenous ligands, and systemic autoimmune diseaseImmunological Reviews, 2005
- Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9Journal of Clinical Investigation, 2005
- Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G ComplexesThe Journal of Experimental Medicine, 2004
- Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responsesNature Reviews Immunology, 2004
- FcγRIIa Is Expressed on Natural IFN-α-Producing Cells (Plasmacytoid Dendritic Cells) and Is Required for the IFN-α Production Induced by Apoptotic Cells Combined with Lupus IgGThe Journal of Immunology, 2003
- Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptorsNature, 2002
- An etiopathogenic role for the type I IFN system in SLETrends in Immunology, 2001